Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus Health Services' subsidiary, Optival Health Solutions, received drug license suspension orders for two stores in Andhra Pradesh and Odisha. The suspensions, lasting seven and two days respectively, carry a combined potential revenue loss of ₹0.07 Crore. The actions were taken due to alleged violations of the Drugs and Cosmetics Rules, 1945.

Key figures
Value₹0.07 Cr
Source

NSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Medplus Health Services Ltd: key numbers

Share price
₹609.40
Market cap
₹7,321 Cr
Revenue (annual)
₹6,892 Cr
Net profit (annual)
₹219.7 Cr
P/E (TTM)
34.7×Sector 52.0×
Promoter holding
40.19%+0.00% QoQ
FII holding
12.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Medplus Health Services Ltd

All →

Other adverse business impact announcements

All →